Acorai

Acorai is at the forefront of medical equipment manufacturing, dedicated to setting a new standard in heart failure management. Acorai is actively developing innovative devices aimed at reducing hospitalizations and readmissions through non-invasive cardiac and pulmonary pressure sensing. The company's groundbreaking product employs machine-learning analysis of pressure dynamics in acoustics, vibratory, and waveform data to monitor cardiac and pulmonary pressure with compelling precision.

Acorai’s technology boasts a low-risk clinical and regulatory pathway, minimizes dependence on reimbursement, and offers a fast track to commercialization. With a versatile hardware solution and world-leading clinical advisors and partnerships, Acorai is committed to delivering clinically proven heart failure vital signs. Acorai's primary address is in Helsingborg, SE, with an additional location in London, GB.

Acorai’s multi-sensor hardware, combined with a multi-disciplined senior management team, drives the company’s mission to prevent heart failure readmissions and improve patient outcomes. Acorai integrates advanced technologies such as AI and digital health solutions to enhance its cardiovascular monitoring capabilities. The team at Acorai are actively working to complete further details about the company which will be released by management soon.

To the manager of Acorai: We invite you to create a customized and exclusive company showcase and product listing on our platform to further enhance your commercial development.